EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$7.11
-1.46%
Mkt Cap $261.81M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+167.4%
Consensus $19.00 vs current $7.11